Qingqin Hao

430 citations
12 papers · 353 indexed · h-index 9
Topics
Cancer-related molecular mechanisms research (5 papers)Hepatitis B Virus Studies (4 papers)MicroRNA in disease regulation (3 papers)

In The Last Decade

Qingqin Hao

12 papers receiving 347 citations

Peers

Qingqin Hao
Comparison fields: 5 of 48
  • Molecular Biology 199
  • Immunology 86
  • Genetics 65
  • Virology 62
  • Oncology 57
Replace Erik W. Martin with:
Erik W. Martin United States
Caryll Waugh Australia
Dominique Vanhecke Belgium
Cosette Rebouissou France
Cécile Desjobert France
Francesca Calderazzo Italy
C Lengel United States
Qingsheng Li China
Karine Boulay Canada
Hitoko Kamisaku Japan
Qingqin Hao relative to Erik W. Martin United States Erik W. Martin's profile →
Citations per field
00.5×3.1×
Erik W. Martin · 1×
Citations per year

Countries citing papers authored by Qingqin Hao

Since Specialization
Citations

This map shows the geographic impact of Qingqin Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqin Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqin Hao more than expected).

Fields of papers citing papers by Qingqin Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingqin Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqin Hao. The network helps show where Qingqin Hao may publish in the future.

Co-authorship network of co-authors of Qingqin Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Qingqin Hao. A scholar is included among the top collaborators of Qingqin Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingqin Hao. Qingqin Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 9
2 3
3 5
4 7
5 13
6 12
7
Differentiation of human CD34+CD38- cord blood stem cells into B cell progenitors in vitro.
48
8 84
9
Localization of the TRK proto-oncogene to human chromosome bands 1q23-1q24.
21
10 18
11 42
12 91

About Qingqin Hao

Qingqin Hao is a scholar working on Cancer Research, Virology and Hematology, having authored 12 papers that have together received 353 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Hepatitis B Virus Studies (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Virology (62 citations), Hematology (47 citations) and Immunology (86 citations). Qingqin Hao has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Nora Heisterkamp, John Groffen, J C Guatelli, Ingrid Bahner, Xiaojin Yu, Donald B. Kohn, Changyong Zhou, Christopher M. Morris, Flávia Torreão Thiemann and GM Crooks. Their work appears in journals such as Molecular and Cellular Biology, Journal of Virology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026